LISATA THERAPEUTICS, INC. business relationships
Companies named in LISATA THERAPEUTICS, INC.’s 10-K filed 2026-03-12, and public companies whose annual reports name LISATA THERAPEUTICS, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- - / 10
- AI naming
- - / 100
- Agent readiness
- - / 100
- AI adoption
- - / 100
Named in LISATA THERAPEUTICS, INC.’s annual report 2
“...ntered into a worldwide Non-Exclusive License Agreement (the "Non-Exclusive License Agreement" or the "Agreement") with Catalent, Inc. ("Catalent"), pursuant to which the Company granted to Catalent, on a non-exclusive basis, certain of its intellectual property to exploit use of the Company's novel...” SEC filing
“...ing the year ended December 31, 2025, and $ 1.0 million during the year ended December 31, 2024 in connection with certain upfront license fees in the current year and the Exclusive License and Collaboration Agreement with Kuva Labs, Inc in the prior year (Note 17) who is based in the United States.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.